Online version ('open access') and editorial work
While we completely modernized the print version with volume 79 (2011), and while it will continue to meet the needs of some of our readers, University libraries, scientific databases and indexing companies, the main focus lies on our online version on www.scipharm.at. Due to the generous support of our parent organizations, the Austrian Chamber of Pharmacists (ÖAK, Österreichische Apothekerkammer) and the Austrian Pharmaceutical Society (ÖPhG, Österreichische Pharmazeutische Gesellschaft), the electronic version of our journal can still be accessed on our homepage without any subscription or registration barriers. Such an open-access model has become more and more frequent in scientific publishing during the last decade. However, it is quite unusual neither readers ('open access') nor authors (no publishing fees) are charged, and this holds true for Scientia Pharmaceutica. This fact guarantees the editorial independence of Sci Pharm.
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The popularity of our online version is still increasing. Figure 1 , which shows the monthly full text downloads from our homepage, documents this. Please note, these incredible numbers do not include 'abstract only views' or the many views on internet sites that have hosted the content of our journal. Of course, these positive circumstances, which ensure that each paper published receives the best possible dissemination and publicity, attract many researchers from around the world as potential authors. Consequently, this led-and still leads-to an increased number of submissions (approximately 400 manuscripts are expected for 2011!).
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Published Articles in Scientia Pharmaceutica
However, because of the expansion of our editorial team-Franz GABOR and Reinhard LÄNGER joined as scientific editors and many new members joined our scientific advisory board (www.scipharm.at/board/)-we are able administrate the rapid peer review process for all submissions. Nevertheless, because 'quality comes first' at Sci Pharm, only the best of the numerous submissions are selected by our expert editors for publication, with the highly appreciated help of many referees. Although we do not have a specific page or paper limit for publication, we are currently publishing around 50-60 papers each year (see figure 2) . While comparing the number of submissions with the number of published articles, it is evident Sci Pharm applies a rigorous peer review for each paper to maintain the high scientific standards (see the current rejection rate of approximately 85% in figure 3 ). 
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